ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,254Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 1000

$870K Total Retail Price of All Prescriptions

Rank: 84 out of 1000

456 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

40% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 11,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,002 573 S3 1 1
LEVOTHYROXINE SODIUM 674 455 2 4
LISINOPRIL 431 349 3 5
OMEPRAZOLE 427 262 4 2
SIMVASTATIN 408 297 5 3
ATORVASTATIN CALCIUM 386 289 6 18
FUROSEMIDE 344 304 7 7
CARVEDILOL 324 251 8 15
TRAMADOL HCL 310 212 9 13
AMLODIPINE BESYLATE 298 247 10 6
CARISOPRODOL 284 73 R 11 72
MELOXICAM 273 167 12 14
PRAVASTATIN SODIUM 258 180 13 12
POTASSIUM CHLORIDE 257 226 14 10
FAMOTIDINE 257 157 14 88
ZOLPIDEM TARTRATE 247 127 16 16
WARFARIN SODIUM 246 228 17 22
NEXIUM 230 115 18 23
PANTOPRAZOLE SODIUM 216 159 19 28
GABAPENTIN 215 148 20 11
METFORMIN HCL 213 122 21 8
ATENOLOL 209 141 22 24
CITALOPRAM HBR 176 128 23 17
PROMETHAZINE HCL 156 42 R 24 54
CRESTOR 145 80 25 30
RAMIPRIL 133 66 26 77
BENAZEPRIL HCL 132 85 27 61
TAMSULOSIN HCL 129 102 28 33
SERTRALINE HCL 127 92 29 26
TRAZODONE HCL 126 72 30 29
AZITHROMYCIN 125 73 31 36
METOPROLOL TARTRATE 124 105 32 19
MIRTAZAPINE 122 105 33 56
NAMENDA 118 111 34 43
ROPINIROLE HCL 111 101 35 82
ZETIA 107 41 36 95
CYMBALTA 105 49 37 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 66 38 20
QUETIAPINE FUMARATE 102 71 39 75
DIOVAN 99 78 40 67
HYDROCHLOROTHIAZIDE 98 83 41 9
CLOPIDOGREL 97 85 42 35
DONEPEZIL HCL 96 87 43 32
AMOXICILLIN 96 57 43 89
ENDOCET 95 28 S2 45 107
EXELON 91 80 46 108
CYCLOBENZAPRINE HCL 90 41 R 47 39
ALLOPURINOL 87 65 48 31
METOCLOPRAMIDE HCL 85 78 49 99
ESCITALOPRAM OXALATE 85 57 49 60
PAROXETINE HCL 82 51 51 63
GLIMEPIRIDE 77 54 52 34
DIVALPROEX SODIUM 77 77 52 113
ENALAPRIL MALEATE 77 54 52 58
RANITIDINE HCL 74 49 55 37
CLONIDINE HCL 72 55 56 27
ISOSORBIDE MONONITRATE ER 71 61 57 71
LYRICA 68 29 58 47
LOSARTAN POTASSIUM 67 39 59 25
AMLODIPINE BESYLATE-BENAZEPRIL 67 50 59 59
SPIRIVA 67 63 59 64
METOPROLOL SUCCINATE 67 45 59 21
HYDRALAZINE HCL 66 54 63 74
FENOFIBRATE 65 57 64 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 41 65 70
FLUTICASONE PROPIONATE 63 54 65 40
LANTUS 63 43 65 68
MEPERIDINE HCL 61 0 S2 R 10 68 365
SYNTHROID 61 48 68 91
ONDANSETRON HCL 60 19 70 204
AMPHETAMINE SALT COMBO 60 0 S2 70 223
PROAIR HFA 60 37 70 50
PLAVIX 59 52 73 49
MECLIZINE HCL 58 50 74 80
FENTANYL 56 43 S2 75 100
KLOR-CON 10 55 34 76 104
KLOR-CON M20 55 50 76 66
VYTORIN 53 31 78 201
BUSPIRONE HCL 53 22 78 110
ALENDRONATE SODIUM 53 33 78 57
ADVAIR DISKUS 52 36 81 65
FLUCONAZOLE 52 27 81 102
FLUOXETINE HCL 51 17 83 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.